Potential disease-modifying therapy for Parkinson’s disease
Drug Discovery World
NOVEMBER 28, 2023
The peer-reviewed article titled ‘Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease (PD) mouse model’ was the result of collaborative work between Cambridge University, Harvard Medical School, and Mission Therapeutics. Parkinson’s disease is highly associated with mitochondrial dysfunction.
52 
Let's personalize your content